[go: up one dir, main page]

AU4338189A - Immunotherapy vaccine for melanoma tumors - Google Patents

Immunotherapy vaccine for melanoma tumors

Info

Publication number
AU4338189A
AU4338189A AU43381/89A AU4338189A AU4338189A AU 4338189 A AU4338189 A AU 4338189A AU 43381/89 A AU43381/89 A AU 43381/89A AU 4338189 A AU4338189 A AU 4338189A AU 4338189 A AU4338189 A AU 4338189A
Authority
AU
Australia
Prior art keywords
vaccine
melanoma
immunostimulant
microorganism
soluble extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43381/89A
Other languages
English (en)
Inventor
Malcolm S. Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Original Assignee
University of Southern California USC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC filed Critical University of Southern California USC
Publication of AU4338189A publication Critical patent/AU4338189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU43381/89A 1988-09-23 1989-09-22 Immunotherapy vaccine for melanoma tumors Abandoned AU4338189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24854388A 1988-09-23 1988-09-23
US248543 1988-09-23

Publications (1)

Publication Number Publication Date
AU4338189A true AU4338189A (en) 1990-04-18

Family

ID=22939592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43381/89A Abandoned AU4338189A (en) 1988-09-23 1989-09-22 Immunotherapy vaccine for melanoma tumors

Country Status (4)

Country Link
JP (1) JPH04501663A (es)
AU (1) AU4338189A (es)
ES (1) ES2019728A6 (es)
WO (1) WO1990003183A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620350D0 (en) 1996-09-30 1996-11-13 Maudsley David J Cancer vaccine
DE60040213D1 (de) 1999-02-09 2008-10-23 Riken Wako Tumorimpfstoff
WO2000071156A2 (en) * 1999-05-21 2000-11-30 Onyvax Limited New vaccine formulations-3
US8409564B2 (en) 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
RU2152800C1 (ru) * 1999-12-08 2000-07-20 Зыбин Дмитрий Владимирович Способ культивирования и модификации гетерогенных клеток млекопитающих
RU2192884C2 (ru) * 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Вакцина для стимуляции противоопухолевого иммунитета
WO2003028758A1 (en) * 2001-09-28 2003-04-10 Haruo Sugiyama Novel method of inducing antigen-specific t cells
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
MXPA06006286A (es) * 2003-12-05 2006-09-04 Univ Montreal Compuestos inmunologicos para prevencion, proteccion, profilaxis o tratamiento de trastornos inmunologicos, infecciones y cancer.
GB0601598D0 (en) * 2006-01-26 2006-03-08 Stathopoulos Apostolos Method
RU2392316C1 (ru) * 2008-12-26 2010-06-20 Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН КЛЕТОЧНАЯ ЛИНИЯ МЕЛАНОМЫ ЧЕЛОВЕКА mel Ksen, ИСПОЛЬЗУЕМАЯ ДЛЯ ПОЛУЧЕНИЯ ПРОТИВООПУХОЛЕВЫХ ВАКЦИН
WO2012156969A1 (en) 2011-05-17 2012-11-22 Hadasit Medical Research Services And Development Ltd. Allogeneic tumor cell vaccination
PL2941233T3 (pl) * 2013-01-07 2021-03-08 The Trustees Of The University Of Pennsylvania Kompozycje i sposoby leczenia chłoniaka z komórek t typu pierwotnie skórnego

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4505900A (en) * 1982-05-26 1985-03-19 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants

Also Published As

Publication number Publication date
WO1990003183A1 (en) 1990-04-05
JPH04501663A (ja) 1992-03-26
ES2019728A6 (es) 1991-07-01

Similar Documents

Publication Publication Date Title
Mitchell et al. Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant
Mitchell et al. Active-specific immunotherapy for melanoma.
US4877611A (en) Vaccine containing tumor antigens and adjuvants
Bucana et al. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells
Weiss MER and other mycobacterial fractions in the immunotherapy of cancer
Wu et al. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma
JP4135190B2 (ja) 免疫治療剤とその使用
Golovliov et al. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis
AU4338189A (en) Immunotherapy vaccine for melanoma tumors
CN107098984B (zh) 牛膝粗多糖、多糖组分和均一多糖、其制备方法及其用途
Shen et al. Immunomopharmacological effects of polysaccharides from Acanthopanax senticosus on experimental animals
Rajasekariah et al. Immunization of mice against infection with Taenia taeniaeformis using various antigens prepared from eggs, oncospheres, developing larvae and strobilocerci
EP0422164B1 (en) Large multivalent immunogen
Klesius et al. Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates
Mel et al. Studies on vaccination against bacillary dysentery: 1. Immunization of mice against experimental Shigella infection
AU2003246396A1 (en) A method for generating antigen-presenting cells
EP0037441B1 (en) Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein
Kedar et al. In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia
Alley et al. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas
US6596282B1 (en) Treatment of chronic viral infections with M. vaccae
EP0615758B1 (en) Anti-tumor vaccines
Parant et al. Biological Properties of Non-Toxic Water-Soluble Immunoadjuvants from Mycobacterial Cells
Kanar et al. Naturally Occurring Cell-Mediated Cytotoxicity Against Simian Virus 40-Transformed 3T3 Murine Tumor Cells
CN115475240A (zh) 新疆栽培一枝蒿粗多糖作为口蹄疫灭活疫苗佐剂的应用
Hojo et al. Cytotoxic lymphocytes in rat tumor in situ: effect of intraperitoneal injections of Propionibacterium avidum